S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BRTX BioRestorative Therapies Inc

1.74

0.0398 (2.34%)

28 Sep 2024 - Closed

Delayed by 15 minutes

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Article too big to display. Click here to view on the SEC website

BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more BioRestorative Therapies Charts.

BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more BioRestorative Therapies Charts.

BioRestorative Therapies Inc News

Form 8-K - Current report
Tuesday 24 September 2024 (4 days ago) • Edgar (US Regulatory)

BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
Thursday 19 September 2024 (1 week ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 August 2024 (1 month ago) • Edgar (US Regulatory)

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
Wednesday 14 August 2024 (1 month ago) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Friday 9 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 August 2024 (2 months ago) • Edgar (US Regulatory)

BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024
Wednesday 7 August 2024 (2 months ago) • GlobeNewswire Inc.

BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine
Tuesday 23 July 2024 (2 months ago) • GlobeNewswire Inc.

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
Thursday 27 June 2024 (3 months ago) • GlobeNewswire Inc.

BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
Monday 17 June 2024 (3 months ago) • GlobeNewswire Inc.

Shares of Biotech MicroCap Rip on Licensing Talks
Friday 14 June 2024 (4 months ago) • AllPennyStocks.com

More BioRestorative Therapies Inc News Articles

Invesco QQQ Trust Series 1

Gold vs US Dollar

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions